Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_assertion type Assertion NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_head.
- NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_assertion wasGeneratedBy ECO_0000203 NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_provenance.
- NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_assertion wasDerivedFrom befree-2016 NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_provenance.
- NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_assertion SIO_000772 11847524 NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_provenance.
- NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_assertion evidence source_evidence_literature NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_provenance.
- NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_assertion description "[The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345271.RABuxRDjNvVYhH2xJ91MclEe-3Ge85i15BT9OXRiHFLy4130_provenance.